These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34368974)

  • 1. Expanding the clinical and genetic spectrum of pathogenic variants in STIM1.
    Ticci C; Cassandrini D; Rubegni A; Riva B; Vattemi G; Matà S; Ricci G; Baldacci J; Guglielmi V; Di Muzio A; Malandrini A; Tonin P; Siciliano G; Federico A; Genazzani AA; Santorelli FM; Merlini L
    Muscle Nerve; 2021 Nov; 64(5):567-575. PubMed ID: 34368974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
    Böhm J; Laporte J
    Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analyses of STIM1 mutations reveal a common pathomechanism for tubular aggregate myopathy and Stormorken syndrome.
    Peche GA; Spiegelhalter C; Silva-Rojas R; Laporte J; Böhm J
    Neuropathology; 2020 Dec; 40(6):559-569. PubMed ID: 33073872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains.
    Harris E; Burki U; Marini-Bettolo C; Neri M; Scotton C; Hudson J; Bertoli M; Evangelista T; Vroling B; Polvikoski T; Roberts M; Töpf A; Bushby K; McArthur D; Lochmüller H; Ferlini A; Straub V; Barresi R
    Neuromuscul Disord; 2017 Sep; 27(9):861-872. PubMed ID: 28624464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation.
    Morin G; Biancalana V; Echaniz-Laguna A; Noury JB; Lornage X; Moggio M; Ripolone M; Violano R; Marcorelles P; Maréchal D; Renaud F; Maurage CA; Tard C; Cuisset JM; Laporte J; Böhm J
    Hum Mutat; 2020 Jan; 41(1):17-37. PubMed ID: 31448844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular aggregate myopathy with features of Stormorken disease due to a new STIM1 mutation.
    Noury JB; Böhm J; Peche GA; Guyant-Marechal L; Bedat-Millet AL; Chiche L; Carlier RY; Malfatti E; Romero NB; Stojkovic T
    Neuromuscul Disord; 2017 Jan; 27(1):78-82. PubMed ID: 27876257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-Function Mutation in STIM1 (P.R304W) Is Associated with Stormorken Syndrome.
    Morin G; Bruechle NO; Singh AR; Knopp C; Jedraszak G; Elbracht M; Brémond-Gignac D; Hartmann K; Sevestre H; Deutz P; Hérent D; Nürnberg P; Roméo B; Konrad K; Mathieu-Dramard M; Oldenburg J; Bourges-Petit E; Shen Y; Zerres K; Ouadid-Ahidouch H; Rochette J
    Hum Mutat; 2014 Oct; 35(10):1221-32. PubMed ID: 25044882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tubular aggregate myopathy and Stormorken syndrome].
    Böhm J; Laporte J
    Med Sci (Paris); 2018 Nov; 34 Hors série n°2():26-31. PubMed ID: 30418142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
    Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
    Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
    Nesin V; Wiley G; Kousi M; Ong EC; Lehmann T; Nicholl DJ; Suri M; Shahrizaila N; Katsanis N; Gaffney PM; Wierenga KJ; Tsiokas L
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4197-202. PubMed ID: 24591628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca
    Riva B; Pessolano E; Quaglia E; Cordero-Sanchez C; Bhela IP; Topf A; Serafini M; Cox D; Harris E; Garibaldi M; Barresi R; Pirali T; Genazzani AA
    Cell Calcium; 2022 Jul; 105():102605. PubMed ID: 35636153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual mechanism promotes switching of the Stormorken STIM1 R304W mutant into the activated state.
    Fahrner M; Stadlbauer M; Muik M; Rathner P; Stathopulos P; Ikura M; Müller N; Romanin C
    Nat Commun; 2018 Feb; 9(1):825. PubMed ID: 29483506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STIM1 over-activation generates a multi-systemic phenotype affecting the skeletal muscle, spleen, eye, skin, bones and immune system in mice.
    Silva-Rojas R; Treves S; Jacobs H; Kessler P; Messaddeq N; Laporte J; Böhm J
    Hum Mol Genet; 2019 May; 28(10):1579-1593. PubMed ID: 30576443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dominant STIM1 mutation causes Stormorken syndrome.
    Misceo D; Holmgren A; Louch WE; Holme PA; Mizobuchi M; Morales RJ; De Paula AM; Stray-Pedersen A; Lyle R; Dalhus B; Christensen G; Stormorken H; Tjønnfjord GE; Frengen E
    Hum Mutat; 2014 May; 35(5):556-64. PubMed ID: 24619930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1.
    Markello T; Chen D; Kwan JY; Horkayne-Szakaly I; Morrison A; Simakova O; Maric I; Lozier J; Cullinane AR; Kilo T; Meister L; Pakzad K; Bone W; Chainani S; Lee E; Links A; Boerkoel C; Fischer R; Toro C; White JG; Gahl WA; Gunay-Aygun M
    Mol Genet Metab; 2015 Mar; 114(3):474-82. PubMed ID: 25577287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.
    Feske S
    Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and muscle MRI features in a family with tubular aggregate myopathy and novel STIM1 mutation.
    Claeys T; Goosens V; Racé V; Theys T; Thal DR; Depuydt CE; Claeys KG
    Neuromuscul Disord; 2020 Sep; 30(9):709-718. PubMed ID: 32893083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the Ca
    Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1.
    Böhm J; Chevessier F; Koch C; Peche GA; Mora M; Morandi L; Pasanisi B; Moroni I; Tasca G; Fattori F; Ricci E; Pénisson-Besnier I; Nadaj-Pakleza A; Fardeau M; Joshi PR; Deschauer M; Romero NB; Eymard B; Laporte J
    J Med Genet; 2014 Dec; 51(12):824-33. PubMed ID: 25326555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminal STIM1 Mutants that Cause Tubular Aggregate Myopathy Promote Autophagic Processes.
    Sallinger M; Tiffner A; Schmidt T; Bonhenry D; Waldherr L; Frischauf I; Lunz V; Derler I; Schober R; Schindl R
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.